T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation.
Clin Immunol
; 149(3): 534-55, 2013 Dec.
Article
em En
| MEDLINE
| ID: mdl-24263283
Palavras-chave
50% inhibitory concentration; ADA; ALN; APC; CFSE; Cell-mediated immunity; ELISA; ELISpot; FPX; FVIII; HLA; IC(50); IEDB; Immune Epitope Database Analysis Resource; Immunogenicity;; MHC; ORG; PBMC; Quality-by-Design;; SFC; T; T cell receptor; T cell;; T-cell dependent, thymus dependent; T-cell independent; TCR; Td; Ti; Treg; aTreg; adaptive regulatory T cells; anti-drug antibodies; antigen-presenting cells; artificial lymph node; carboxyfluorescein succinimidyl ester; enzyme-linked immunosorbent assay; enzyme-linked immunosorbent spot-forming; factor VIII; human leukocyte antigen; iTreg; induced regulatory T cells; major histocompatibility complex; nTregs; natural regulatory T cells; peripheral blood mononuclear cells; recombinant Fc fusion protein; regulatory T cells; spot-forming cells; thymus; unmodified original epitopes
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Produtos Biológicos
/
Linfócitos T
/
Imunidade Celular
Tipo de estudo:
Prognostic_studies
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Clin Immunol
Assunto da revista:
ALERGIA E IMUNOLOGIA
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
Estados Unidos